Judgement Briefs

Constitutional Law

Hoechst Pharmaceuticals Ltd. v. State of Bihar

AIR 1983 SC 1019; (1983) 4 SCC 45

Citation
AIR 1983 SC 1019; (1983) 4 SCC 45
Court
Supreme Court of India
Date
6 May 1983
Bench
A.P. Sen; E.S. Venkataramiah; R.B. Misra

Facts

  • The Bihar Finance Act, 1981 imposed a surcharge upon dealers whose annual gross turnover exceeded ₹5 lakh.
  • The surcharge could be fixed at a rate not exceeding ten per cent of the sales tax payable.
  • Section 5(3) prohibited liable dealers from separately collecting the surcharge from purchasers.
  • Hoechst Pharmaceuticals and other manufacturers sold medicines whose prices were controlled under the Drugs (Prices Control) Order issued under the Essential Commodities Act, 1955.
  • They argued that because they could not increase the controlled price, they had to bear the surcharge from their own profits.
  • They challenged the Bihar provisions on several constitutional grounds, including:
  • lack of State legislative competence;
  • repugnancy with the Central price-control law;
  • discrimination; and
  • improper consideration of interstate and outside sales in computing gross turnover.

Issue

  • Whether the surcharge was a tax on the sale of goods within Entry 54 of List II.
  • Whether the State law was repugnant to the Drugs (Prices Control) Order under Article 254.
  • Whether Article 254 applies where the State and Union laws fall under different legislative lists.
  • Whether outside and interstate turnover could be considered for classifying dealers liable to pay surcharge.
  • Whether prohibiting recovery of the surcharge from consumers was unconstitutional.

Rule

  • A surcharge upon sales tax is itself in the nature of an additional sales tax.
  • The State’s competence under Entry 54 includes power to:
  • select the class of dealers liable; and
  • prohibit the dealer from passing the tax to the purchaser.
  • Article 254 concerns repugnancy only where both Parliament and the State Legislature legislate upon the same matter in the Concurrent List.
  • Where a State law under List II overlaps with a Union or Concurrent field, the question is one of:
  • legislative competence; and
  • pith and substance, not repugnancy under Article 254.
  • State legislation may consider wider turnover for classification, provided the actual tax is imposed only upon constitutionally taxable sales and a sufficient territorial nexus exists.

Application

  • The surcharge was calculated as a percentage of the sales tax payable.
  • Its true character was therefore an additional tax on sales, not a tax upon income or profits.
  • The State Legislature was competent under Entry 54 of List II.
  • The Central law and the Bihar law served different purposes:
  • the Drugs (Prices Control) Order regulated the maximum price and distribution of essential medicines;
  • the Bihar Act raised State revenue through sales taxation.
  • The prohibition on passing the surcharge to purchasers did not alter the controlled price fixed by the Central Order.
  • It merely required the manufacturer or dealer to absorb the additional tax.
  • The two laws could operate simultaneously.
  • Article 254 did not apply because the Bihar surcharge arose under the exclusive State taxing entry, while the Central price-control measure arose under Entry 33 of the Concurrent List.
  • The Court also upheld the use of gross turnover, including certain interstate or outside transactions, to identify financially stronger dealers.
  • Those outside sales were not themselves taxed.
  • They were used only to determine whether the dealer crossed the ₹5 lakh threshold.
  • The actual surcharge remained confined to taxable sales within Bihar.
  • Because the appellants carried on substantial business within Bihar, the required territorial nexus existed.
  • No evidence showed that the burden was confiscatory or that the classification was irrational.

Conclusion

  • The Supreme Court upheld Sections 5(1) and 5(3) of the Bihar Finance Act.
  • The surcharge was within Entry 54 of List II.
  • There was no repugnancy with the Drugs (Prices Control) Order.